Evidence map›Paper›PMID 26936609›Full record

ArticleClinical oncology (Royal College of Radiologists (Great Britain))2016

Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service.

E J A Morris, P J Finan, K Spencer, I Geh, A Crellin, P Quirke, J D Thomas, S Lawton, R Adams, D Sebag-Montefiore

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Clinical oncology (Royal College of Radiologists (Great Britain)), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07054047 (Improving the Prognostic Accuracy of Staging Rectal Cancer Using Magnetic Resonance Imaging), which is not on this map. Cited by 29 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 2 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07054047 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Improving the Prognostic Accuracy of Staging Rectal Cancer Using Magnetic Resonance Imaging (MRI) - Detected Tumour Deposits and Vascular Invasion (mrTDV) Instead of Tumour Nodal Metastasis (mrTNM)

TypeinterventionalSponsorImperial College LondonRan2025 to 2031Enrolled438ConditionsGI CancerArmsmrTDV
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Radiation-induced changes in gene expression in rectal cancer specimens.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Review
  7. Article
  8. Article
  9. What is the impact of hospital and surgeon volumes on outcomes in rectal cancer surgery?Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020.Clinical oncology (Royal College of Radiologists (Great Britain)) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

E J A MorrisCancer Epidemiology Group, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds, UK. Electronic address: e.morris@leeds.ac.uk.
P J FinanJohn Goligher Colorectal Unit, St James's University Hospital, Leeds, UK; National Cancer Intelligence Network, London, UK.
K SpencerCancer Epidemiology Group, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds, UK; Non-Surgical Oncology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
I GehUniversity Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Medical Centre, Birmingham, UK.
A CrellinNon-Surgical Oncology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
P QuirkeSection of Pathology and Tumour Biology, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds, UK.
J D ThomasNational Cancer Registration Service, Northern and Yorkshire Office, St James's Institute of Oncology, St James's University Hospital, Leeds, UK; Knowledge and Intelligence Team (Northern and Yorkshire), St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
S LawtonKnowledge and Intelligence Team (Northern and Yorkshire), St James's Institute of Oncology, St James's University Hospital, Leeds, UK.
R AdamsCardiff University School of Medicine, Velindre Hospital, Cardiff, UK.
D Sebag-MontefioreSection of Clinical Oncology, Leeds Institute of Cancer & Pathology, University of Leeds, St James's University Hospital, Leeds, UK.
St James's University Hospital · GBLeeds Teaching Hospitals NHS Trust · GBUniversity Hospitals Birmingham NHS Foundation Trust · GBUniversity of Leeds · GBVelindre NHS Trust · GB

Funding

Cancer Research UK 15954Cancer Research UK C23434/A9805Medical Research Council MR/L01629X/1
6 · The paper itself

Abstract

aimsRadiotherapy is an important treatment modality in the multidisciplinary management of rectal cancer. It is delivered both in the neoadjuvant setting and postoperatively, but, although it reduces local recurrence, it does not influence overall survival and increases the risk of long-term complications. This has led to a variety of international practice patterns. These variations can have a significant effect on commissioning, but also future clinical research. This study explores its use within the large English National Health Service (NHS). MATERIALS AND

methodsInformation on all individuals diagnosed with a surgically treated rectal cancer between April 2009 and December 2010 were extracted from the Radiotherapy Dataset linked to the National Cancer Data Repository. Individuals were grouped into those receiving no radiotherapy, short-course radiotherapy with immediate surgery (SCRT-I), short-course radiotherapy with delayed surgery (SCRT-D), long-course chemoradiotherapy (LCCRT), other radiotherapy (ORT) and postoperative radiotherapy (PORT). Patterns of use were then investigated.

resultsThe study consisted of 9201 individuals; 4585 (49.3%) received some form of radiotherapy. SCRT-I was used in 12.1%, SCRT-D in 1.2%, LCCRT in 29.5%, ORT in 4.7% and PORT in 2.3%. Radiotherapy was used more commonly in men and in those receiving an abdominoperineal excision and less commonly in the elderly and those with comorbidity. Significant and substantial variations were also seen in its use across all the multidisciplinary teams managing this disease.

conclusionDespite the same evidence base, wide variation exists in both the use of and type of radiotherapy delivered in the management of rectal cancer across the English NHS. Prospective population-based collection of local recurrence and patient-reported early and late toxicity information is required to further improve patient selection for preoperative radiotherapy.

Indexed as

AgedChemoradiotherapyFemaleHumansMaleMiddle AgedNeoadjuvant TherapyProspective StudiesRadiotherapyRectal NeoplasmsState MedicineUnited KingdomRadiotherapyrectal cancersurgery

Identifiers

PMID26936609
PMCPMC4944647
OpenAlexW2281289152

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.